hexanoic acid has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, S; Jiang, Y; Li, X; Liu, C; Wang, J; Wang, Y; Xing, H; Zha, W; Zhang, Y | 1 |
1 other study(ies) available for hexanoic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Bivalent mRNA vaccines against three SARS-CoV-2 variants mediated by new ionizable lipid nanoparticles.
Topics: Antibodies, Viral; BNT162 Vaccine; COVID-19; Decanoates; Esters; Humans; mRNA Vaccines; Nanoparticles; SARS-CoV-2; Vaccines, Combined | 2023 |